Skip to main content
. Author manuscript; available in PMC: 2017 Dec 9.
Published in final edited form as: Clin Cancer Res. 2011 Oct 5;17(22):7183–7193. doi: 10.1158/1078-0432.CCR-11-0981

Figure 1.

Figure 1

Baseline CTC Positivity and Patient Survival. A. CK19mRNA+ and Progression-free Survival. B. MGB1mRNA+ and Progression-free Survival C. CK19mRNA+ and Overall Survival. D. MGB1mRNA+ and Overall Survival. E. CK19mRNA+ and MGB1mRNA+ and Overall Survival.